To better diagnose and provide personalized treatment for patients with asthma and chronic obstructive pulmonary disease (COPD), it is necessary to gain a better understanding of the factors influencing these conditions and how they interact. Artificial intelligence and machine learning will be used to develop multidimensional models to predict the risk of key clinical outcome measures.
